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Abstract
Earl Brewer discusses his journey into pediatric rheumatology from 1958 to retirement in 1990 in
three parts.
Part I: the early years
Introduction
Who is the father of pediatric rheumatology?
"I think I saw it arrive, although I cannot specify its birth-
day or place and I am damned if I can read the father's sig-
nature on the birth certificate. We are very fortunately a
small enough group to know each other personally and to
cooperate and enjoy each other's company." Eric Bywa-
ters, Park City I Meeting. 1976, [figure 1].
"Thirteen physicians including two Nobel Laureates in
1932 held the first meeting of the American Committee
for the Control of Rheumatism. In five years it became the
American Rheumatism Association (ARA). I first attended
the seventh meeting of the ARA in June 1940. Only five
papers were presented. Three (60%) of the papers were
devoted to children with rheumatic disease. One of the
papers was by Dr. William Green, an orthopedist at the
Children's Hospital in Boston. His subject, "Mono-articu-
lar and Pauciarticular Arthritis in Children." J. Sydney
Stillman, Park City II Meeting. 1986
"In the beginning we were a handful of naïve but eager
and explorative, young physicians of disparate training,
background, and temperament. We joined together with a
vision of doing whatever was necessary to find better ways
to study the rheumatic diseases of childhood and adoles-
cence, and to treat our patients more effectively in a com-
prehensive continuum of care." Earl Brewer and Joseph
Levinson, Foreword, Textbook of Pediatric Rheumatol-
ogy. 2005
As I enter my seventy-ninth year, my attention turns to
committing to paper, memories and thoughts about my
professional journey into what we now call pediatric
rheumatology. Since my retirement seventeen years ago,
several colleagues and friends have encouraged me to
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describe the road on which we all traveled to provide bet-
ter care and research for children with arthritis.
My approach will be to share personal memories and
thoughts about how I came to the table and what hap-
pened along the way. There will be no attempt at a global
history of our field and no attempt to impartially tell the
story of others who labored so diligently to help the chil-
dren. Landmark concepts, occasions, or events in pediatric
rheumatology will be identified, and the development of
each concept or event carried forward.
I shall share my thoughts in the first person as a writing
technique, which limits my scope to what I personally
know or have been told. I carefully kept records of the
journey from 1958 to 1992. For the interested reader, the
papers are located in the, John P. McGovern Historical
Collections and Research Center, Houston Academy of
Medicine, Texas Medical Center Library, 1133 John Free-
man Blvd., Houston, Texas 77030-2809,. For further
information call 01-713-799-7145. The collection is
housed in 48 boxes that occupy over 48 cubic feet. They
are available by appointment through Ms. Elizabeth
White, Director of the McGovern Center. The finding aid
is also digitized on the Internet site of the library under
manuscripts.
My partner along the way, my wife, Ria, has always been
integral to all of the steps on the journey. I dedicated four
books to Ria with the lines, "To Ria, the best of the best.
With such apparent ease, she makes everything possible."
Overview
There were three ten-year plans for the development of
pediatric rheumatology from 1958 to 1990.
The 1960's: Our efforts started when the old March Of
Dimes became interested in arthritis. They applied the les-
sons learned from polio. The first special treatment cent-
ers for children with arthritis started in 1960. Now we
needed a common base to talk to each other. The Ameri-
can Rheumatism Association appointed the JRA Subcom-
mittee of the Classification Committee in 1964. This
event persuaded several of us in England and the USA to
fill out lengthy questionnaires concerning the clinical
course of children we all thought had JRA. The resulting
data allowed preparation of what we called "JRA Criteria"
published in 1972. The database was subsequently
expanded and checked for usefulness.
The 1970's: With the criteria as a stepping-stone, it became
clear that we needed drugs to treat children with JRA. We
developed a methodology to study medicines for children
with JRA. This led to the formation of the Pediatric Rheu-
matology Collaborative Study Group in 1973. The next
step was to develop a council to have a voice in the affairs
of the ARA. The council's first project was a meeting of
physicians interested in pediatric rheumatology. The
Arthritis Foundation, ARA, and the Shriners of North
America sponsored the meeting in Park City, Utah in
1976. The first supplement devoted to pediatric rheuma-
tology was the best selling supplement in the history of
the Arthritis and Rheumatology journal. [1]
An unexpected benefit was our inclusion in international
rheumatology by way of the USA-USSR scientific cooper-
ation program supervised by the National Institutes of
Health in 1975. Ties with colleagues in Europe led to an
international pediatric rheumatology meeting in Oslo in
1977.
The 1980's: The American Academy of Pediatrics was per-
suaded to form a pediatric rheumatology section of the
AAP in 1980. Attention was needed to develop centers to
give coordinated care for children with arthritis. The
Maternal and Child Health Bureau of the US government
selected pediatric rheumatology for development. We
joined forces with them to form many regional pediatric
rheumatology centers under a special program (SPRANS-
Special Programs of Regional and National Significance)
and develop a host of innovations. The Bureau sponsored
a pivotal meeting in Houston in 1984, New Horizons in
Pediatric Rheumatology.
1984 was a busy year in that we also had the first Ameri-
can Juvenile Arthritis Organization meeting in Keystone,
Colorado, under the auspices of the Arthritis Foundation.
The last of the eighties was perhaps the most satisfying.
We petitioned for a board of Pediatric Rheumatology in
1980, and in 1990 the American Board of Pediatrics and
the American Board of Medical Specialties formally
approved formation of the Board.
The early years
My first exposure to the problems of children with arthri-
tis occurred when I was a Senior Resident in Medicine at
the Boston Children's Hospital in 1956 and1957. [figure
2] Dr. Charles Janeway was Physician-in-chief and Chair.
The six senior residents met with him at eight each Mon-
day morning in his office in the old hospital building on
the second floor. We discussed what had happened in the
hospital over the weekend. My first experience at the Bos-
ton Children's Hospital was like Crocodile Dundee com-
ing to the United States. My previous training was at
Baylor University College of Medicine and the pediatric
program in Houston. The journey to Boston was my first
trip away from Texas except in the army in California. I
was not just wet-behind-the-ears, I was very wet every-
where. I was six feet three inches and weighed about 130Pediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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pounds. I was not just skinny – I looked anorexic. I did
have a nice smile. My professional journey from Houston
to Boston is interesting in itself and will be discussed later.
The hospital program had six senior residents and twenty-
four junior residents. Three of the senior residents were
selected from the junior resident group each year, and
three senior residents were from the outside. Dr. Janeway
wanted to prevent inbreeding of the program and used
this method of germinal seeding.
I was one of the three outsiders. After we became friends
later in the year, Bob Berg, a fellow senior resident and
homegrown Harvard man, asked how it felt to have over-
come an inferior educational background and made it to
the big time. Texas had not qualified as big time at that
juncture east of the Charles River.
One Monday, Peter Auld, the chief resident, and Dr. Jane-
way lamented how the children with JRA were so poorly
treated. Dr. Janeway was concerned about the children
receiving long-term hospitalization at the rheumatic fever
hospital, the House of Good Samaritan. Rheumatic Fever
was rapidly becoming history because of penicillin, and
the children with JRA were housed at the "Good Sam."
The hospital was part of the Children's complex, and the
senior residents covered the needs of the Good Sam on an
as-needed basis.
I was assigned the task to review all of the children who
had been admitted to the hospital, mainly in the affiliated
House of Good Samaritan, over the years. I spent many
hours reviewing voluminous charts. The idea was to write
a review paper and show how many problems existed
with these children and how we needed better ways to
treat them. The records were not uniform, and gathering
decent data were not possible. In general, many of the
children were put to bed and many just shriveled in size
and stature. A genesis of the interest in the care of these
children was the perceived rivalry with the Massachusetts
General Hospital adult rheumatology program under Dr.
Marion Ropes. The pediatricians felt that the adult physi-
cians' approach was not what we would like. I reluctantly
told Dr. Janeway that the records could not be used prop-
erly. The time I spent reviewing these children's charts,
however, left me with a nagging worry about the care of
these children. I also learned a valuable lesson from the
records: One must always make sure that an adequate
and planned record is made of clinical material. This
lesson was key to whatever success occurred later in my
career.
Texas Children's Hospital, Baylor College of Medicine, and Kelsey 
Seybold Clinic
In 1958 I returned to Houston as Chief Resident at Texas
Children's Hospital by prior arrangement as part of my
Jesse H. and Mary Gibbs Jones fellowship to Boston agree-
ment. The hospital was only four years old and in its
infancy as an institution. Dr. Blattner was chair and phy-
sician-in-chief. He was my mentor and friend. His broad
vision made the hospital and pediatric department a huge
success during his tenure. He promoted the idea that par-
ents should stay in the hospital room and participate in
the care of their children. The parents were only allowed
to visit at certain times of the day at other Children's Hos-
pitals.
He could not afford to hire expensive, established special-
ists for his department, so he sent promising young peo-
ple to other centers in the country and brought them back
to Houston. I spent the year as chief resident innovating
such things as the development of our resident teaching
conferences and a system of discharge summaries. I also
learned many lessons in my attempts to integrate effective
interaction between the private physicians and the resi-
dent staff. The hospital became incredibly busy, and our
100 beds were woefully inadequate. One major program
consumed much of my personal interest. Dr. Dan McNa-
mara and Dr. Denton Cooley were developing their now
world-famous cardiology program. Dr. Blattner allowed
me to spend two months with Dan as a fellow in cardiol-
ogy. At the end of my chief residency, I contemplated join-
ing the Cardiology section, but economic circumstances
dictated private practice in the nearby town of Wharton
with Dr. Bolton Outlar, also a friend and mentor.
It was at this point that Dr. Blattner discussed my future
and how I could best participate in academic medicine,
research, and practice. The evolution of the Texas Chil-
dren's Hospital/Baylor College of Medicine arthritis pro-
1957 House staff – children's hospital – Boston Figure 2
1957 House staff – children's hospital – Boston. Brewer is 
fifth from left, front row. Dr. Janeway is sixth, Dr. Peter Auld 
is seventh, Dr. Fred Rosen is last on right, second row, Dr. 
Joel Alpert is fifth from left, top row.Pediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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gram began in early 1958 when Dr. Blattner and I began a
series of talks concerning treatment of children with rheu-
matoid arthritis. My nagging concern about these children
persisted since my time in Boston. Rheumatic fever hospi-
tals closed as penicillin treatment and time reduced the
incidence. We were concerned that the children with juve-
nile rheumatoid arthritis (JRA) were not being treated
properly. We learned from Dr. William Spencer's work
with polio that active exercise was always better than
excessive rest. Dr. Blattner asked me to look into the situ-
ation and begin an arthritis program at TCH. We pro-
moted the concept of keeping the children at home and in
school with hospitalization almost always a last resort.
We also promoted the idea of keeping children as active as
possible even when pain was present.
Dr. William Clark in 1958 took over the March of Dimes
when they were searching for a new disease to solve after
conquering polio. Dr. Blattner and I spoke with Bill Clark
and told him of our program of strengthening muscles
and continued active exercise and activity because of data
showing that enforced rest results in atrophy and weak-
ness, not improvement. He understood and invited me to
his Vanderbilt meeting in Nashville in 1959 to discuss his
plans for the March Of Dimes (more about that meeting
in a separate section).
The clinic took place one morning each week in the Junior
League Clinic of the Texas Children's Hospital in 1958
with myself as the physician, a nurse and volunteers in
attendance. Medical students, pediatric residents, and
nursing students were assigned to the clinic for that partic-
ular morning of the clinic. Within a short time the March
Of Dimes Special treatment Center was funded. Our own
physical therapy room was approved and was essential to
our success.
The program was a strictly a shoestring operation. I prac-
ticed an hour away from the hospital in a small town and
came to TCH one day a week for the program. The addi-
tion of our own physical therapy room illustrates the
primitive structure of our efforts. Dr. Blattner and I shared
offices on the main floor of the hospital just off the mod-
est lobby. The personnel director had a private bathroom
at the end of the hall, which infuriated Dr. Blattner and
Leopold Meyer, Chairman of the Board of the hospital.
Dr. Blattner and I sneaked into the room one day to meas-
ure the space to see if we could put our just approved
physical therapy unit there. Lo and behold, Mrs. Smith-
son, the personnel director, came into the bathroom, and
we hid in a stall. She never found us, and we liberated the
space for our new effort.
The early structure of our approach was pragmatic, and we
dealt with the resources at hand. Health insurance in
Texas would not pay for prolonged hospitalization of
these children. A major objective of the clinic was to pro-
vide long term ambulatory care to not only the child but
also the family through the duration of illness. Another
major objective of treatment was reduction of pain and
discomfort, prevention of deformities, and maintenance
of general health and well-being.
A landmark event occurred when I was allowed to hire
Mrs. Elizabeth Barkley In 1960 as our first physical thera-
pist through a grant from the March Of Dimes (more later
about the MOD). Elizabeth previously was director of the
physical therapy school at the Hermann Hospital in the
Texas Medical Center. She was also a member of the Texas
Board of Physical Therapy. My good fortune was that she
shared our missionary zeal to do our best to improve care
for the children with arthritis.
We developed what we termed a Home Treatment Pro-
gram (HTP). A consulting orthopedic surgeon was added
about this time. The children were evaluated in the clinic,
and a treatment program of daily, active, planned exercise
and heat at home was planned. Two or three visits to our
hospital physical therapy department each week were not
sensible or economically possible for a child with a
chronic condition. The program consisted of parental
education with emphasis on the daily exercise routine of
the patient under the guidance of the parent. The child
and parents were instructed in the daily heat and exercise
program and were checked at weekly intervals by the
physical therapist. When the program was fully under-
stood and established, the child and parent were checked
only at regular clinic visits. Unfortunately our only medi-
cations were aspirin and steroids, and steroid use was in
an early stage and was poorly understood.
The modalities used were warm tub baths twice each day
followed by a formal exercise program. These exercises
were adapted to fit the needs of the individual child and
designed to prevent atrophy and maintain range of
motion. Active exercise was encouraged as opposed to
passive exercise. In situations of severely involved joints,
active, assistive exercise was employed to maintain nor-
mal range of motion. Play activities that could be carried
on for a long period during the day and produce the
desired strengthening and range of motion were outlined
for the child. Night splints were used sparingly to increase
range-of-motion.
An important aspect of the program was emphasis on
encouraging the child to carry on ordinary activities at
home and school. The parents and siblings were
grounded in treating the child as any other member of the
family including doing chores.Pediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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Our companion instructional booklet, The Home Treat-
ment Program, for parents and children with arthritis was
published in the early 1960s and received national and
international recognition [2]. All of us were pleasantly
surprised at the improvement shown by the children who
followed our program. It was clear to me that active exer-
cise is almost always better than the then recommended
prolonged bed rest regimens.
Early interaction with adult rheumatology world
From the beginning, a perceived tension existed between
the adult rheumatologists trained in internal medicine
and pediatricians beginning to care for these children.
There were fundamental differences in training and
approach to the care of children and in particular, chil-
dren with arthritis. Each group felt self-righteous and
absolutely sure that its view was correct. It should be men-
tioned that the American Academy of Pediatrics (AAP)
was not organized until the early 1930s. The AAP was cre-
ated largely because the American Medical Association
(AMA) refused to support the formation of The Children's
Bureau, and physicians fighting for immunizations for
children split from the AMA. A separate department of
pediatrics was not formed at Baylor until Dr. Blattner was
hired in 1947. The scene was set with a background of dis-
trust on the part of the pediatricians protecting their newly
created independence and a perceived patronizing atti-
tude of the adult rheumatologists toward the pediatri-
cians.
I first attended a meeting of the then American Rheuma-
tism Association in the late 1950s. I attended with my new
friend, Dr. James Kemper. He had recently arrived in Hou-
ston from the Mayo Clinic to be in charge of rheumatol-
ogy in the Department of Medicine at Baylor and
rheumatologist at the then small Kelsey Seybold Clinic.
Fortunately for me and my career in pediatric rheumatol-
ogy, we both liked each other from the beginning and
began a professional life and friendship together that has
lasted until now.
The whole experience was incredible. I enjoyed learning
about the huge world of arthritis, and I was impressed
with the caliber of the adult rheumatologists. I also came
away with the certain knowledge that the adult physicians
had a frame of reference with regard to care that was fun-
damentally different from pediatricians. It was more than
the usual cliché that children are not little adults,
although that was certainly one facet of the differences.
Another cliché was that if internists wanted to take care of
children, they would have become pediatricians. Clearly,
there were internists who loved caring for children also.
I met Dr. William Clark, who trained at the Massachusetts
General Hospital with so many legends of rheumatology
including Dr. Ronald Lamont-Havers, then with the
Arthritis Foundation in New York, Dr. Sydney Stillman,
Director of the Robert Brigham Hospital at Harvard, Dr.
John Ward of Salt Lake City, and Dr. Morris Ziff, another
legend of rheumatology. Sydney Stillman ran a children's
clinic at the Robert Brigham Hospital in Boston, but he
did not have a close relationship with the Boston Chil-
dren's Hospital. He was one of the great men I have
known and became a mentor for me. I wish I had known
him when I was a resident in Boston.
However the conclusions that I drew from my early, lim-
ited experiences were clear to me. The path to better care
and research for children with arthritis had be a joint jour-
ney with the adult rheumatology world but must be led by
pediatricians. I followed this concept until my retirement
in 1990. The concept led to some memorable battles
along the way.
In the late 1950s several other pediatricians and internists
were devoting time to caring for children with arthritis in
several parts of the country. We all became devoted col-
leagues in our quest for better care and research for the
children with arthritis. Others will hopefully tell the sto-
ries of the early beginnings of their clinics and their jour-
neys into pediatric rheumatology.
The pioneers
The experiences related in my journey were shared com-
pletely with a large number of dedicated legends of our
field along the way. A few impressions are given here
about the pioneers who began in the 1950s:
Dr. James Cassidy, Ann Arbor–University of Michigan, Omaha–
Creighton Medical School, Columbia–University of Missouri [figure 3]
I can't remember when I first met Jim, but we were friends
from the beginning. He was a type A, rapid-thinking but
careful physician. Jim was our resident genius and writer.
His gentle smile and a humorous gleam in his eye added
to his disciplined approach to any task. Jim was prema-
turely bald and was famous for his caps. He was trained in
internal medicine at the University of Michigan and later
passed boards in both medicine and pediatrics. He
became Chair and Professor of Pediatrics at Creighton
University and moved to the University of Missouri later
and limited his rheumatology patients to children. He was
well known among his peers for eating dinner at precisely
six in the evening for reasons unclear to any of us. We have
remained close friends and colleagues over the years.
Jim, among many accomplishments, is the co-author with
Ross Petty of the standard Textbook of Pediatric Rheuma-
tology published many years later. He and his wife, Nan,
were high school sweethearts in Oil City, Pennsylvania.
He was a consensus builder in our group. His interest inPediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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children with arthritis started at Michigan during his train-
ing. He felt no one was looking after the children. He
encountered resistance from his adult rheumatology staff
from the beginning and had to make sacrifices to con-
tinue. He felt the same need the rest of us felt and became
a staunch and extremely important pioneer in our efforts.
Dr. Joseph Levinson, Cincinnati Children's Medical Center, University 
of Cincinnati [figure 4]
Joe Levinson is another giant legend of our field. We were
so fortunate for his presence in our small group. He was a
reflective, Talmudic person. (Talmudic scholarship is
famous for the tortuous and painstaking manner in which
truth is pursued and established–if it can be established at
all.) Joe would agonize over a single word included in our
various publications. Jim Cassidy and I at times threat-
ened him with extinction if he didn't finish editing a given
paper and give approval. Joe trained in adult rheumatol-
ogy at the MGH in Boston. He entered pediatric rheuma-
tology almost by chance. He filled in at a pediatric clinic
in Cincinnati, which has become a premier program of
pediatric rheumatology. His vision for his center-to-be
was incredible. His persona filled the room when he
entered. He was a jolly-everyone's-Dr. Joe. His soft-spoken
words flowed with ease. His physical stature was spare. He
was and is truly a gentle man.
Dr. Chester Fink, Dallas, Southwestern Medical School, Scottish Rite 
Hospital [figure 5]
Chester Fink was another legend and a wonderful pedia-
trician from North Carolina who trained at Case Western
Reserve and was a friend of Bill Clark. Chet settled at
Southwestern Medical School in Dallas and started a
clinic at the Scottish Rite Hospital for Children and
worked with Morris Ziff, head of the adult rheumatology
program and another legend of rheumatology. Chet loved
to eat and was pleasantly plump. His sense of humor was
a pleasure for all of us. His quiet and reflective approach
to the problems at hand always made sense. His cheeks
were red, topped by horn-rimmed glasses. His ready smile
and laugh lightened many a tense situation, as each of us
pressed our personal agendas during our deliberations.
He became a great friend. Chet met his wife, Dotty, when
they were both stationed in Japan in the army. They
retained their love of Japan and Chet was our main con-
tact person for Asia in our collegial press to develop better
care for children with arthritis.
Dr. Virgil Hanson, Los Angeles, Children's Hospital of Los Angeles, 
University of Southern California [figure 6]
Virgil was a reserved, thoughtful, wonderful human being
and another pioneer and legend. He trained at Johns Hop-
kins and settled in Los Angeles at USC and the Children's
Hospital where he established what became a premier
program. Virgil spoke softly and endeared himself to eve-
ryone who had the privilege of knowing him. He was
always positive in his reaction to ideas. I never heard him
speak ill of anyone, even when a person had really pulled
a sneaky end-run around him or one of his many success-
ful projects.
Dr. Sydney Stillman, Boston, Robert Breck Brigham Hospital, 
Harvard Medical School
Sydney was a distinguished adult rheumatologist at the
Robert Breck Brigham Hospital in Boston, where he was
medical director, and had pioneered a clinic for children
with arthritis on a limited basis. He soon became presi-
dent of the ARA. Sydney, who was older than the rest of
Dr.Joseph Levinson Figure 4
Dr. Joseph Levinson.
Dr.James Cassidy [R], Dr. Earl Brewer [L], Dr. Edward Gian- nini [C] Figure 3
Dr. James Cassidy [R], Dr. Earl Brewer [L], Dr. Edward Gian-
nini [C].Pediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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us, became everyone's Uncle Syd. He was a gentleman in
every way with a wonderful sense of humor that diffused
many a tense situation. Syd was not only my professional
hero but also a mentor as time progressed.
Dr. Jerry Jacobs, New York City, Columbia College of Physicians and 
Surgeons [figure 5]
Jerry Jacobs was another legend in pediatric rheumatology
and an excellent pediatrician at Columbia in New York
City. Jerry trained at Columbia and started a clinic at
Babies Hospital. The entire room knew when Jerry
entered. He was larger than life. Every event was a crisis to
be solved. He had a heart of gold, but as a card-carrying-
tough New Yorker, it was sometimes hard to find. Jerry
was almost always the last to agree on any decision of our
early collegial group and offered constructive opposition
that became important to making our work relevant and
credible. Ilona Szer and Yukiko Kimura in the pediatric
rheumatology online journal gave a wonderful summary
of Jerry and his work [3].
Eleven pivotal events in the development of 
pediatric rheumatology
I : Dr. William Clark and the March Of Dimes (MOD)
Dr. William Clark, Medical Director of the MOD, was a
dynamic, maverick leader of rheumatology who was rest-
less to take rheumatology to the next level of organization
and success. Bill was a professor at Case Western Reserve
when he accepted the challenge from Basil O'Connor and
the MOD. Joe Levinson remembers that Bill visualized a
three-tiered approach to childhood connective diseases. 1.
Case finding with primary treatment facilities to be estab-
lished in local communities at evaluation centers close to
where patients live. 2. Special Treatment Centers would
provide more expert and multidisciplinary services at aca-
demic institutions and would relate to the third tier. 3.
Research Centers could be in the same center as the special
treatment centers.
Bill was later the editor of the prestigious Arthritis and
Rheumatism journal and led the merger of the ARA with
the Arthritis Foundation. When he was president of the
AF, Bill created the highly successful Arthritis Health Pro-
fessions Section. Bill Clark knew that something had to be
done about the care of children with arthritis. He was
interested in our program of strengthening muscles and
continued active exercise and activity because of data
showing that enforced rest results in atrophy and weak-
ness, not improvement. He agreed with us. This concept
was discussed at the Vanderbilt meeting that he organized
in Nashville in 1959.
Vanderbilt meeting – 1959
The host for the meeting was Dr. Amos Christie, a revered
Chairman of Pediatrics at Vanderbilt Medical School.
Invited distinguished rheumatologists were Drs. William
Clark, Howard Polley of the Mayo Clinic (a pioneer in the
use of cortisone), Walter Bauer of Harvard and the Mass
General Hospital, Joseph Bunim, Director of the National
Institutes of Health, Charles Short from Harvard, Charles
Christian, John Calabro, and a few others whose names
escape me. Most were revered leaders of rheumatology. I
was the only pediatrician present except for Dr. Christie.
My assigned roommate was Chuck Christian who had just
finished his fellowship at Columbia College of Physicians
and Surgeons with Charles Ragen, another legend. Chuck
had just joined the faculty at Columbia. He was an incred-
Dr. Virgil Hanson [R] and Dr. Earl Brewer [L] Figure 6
Dr. Virgil Hanson [R] and Dr. Earl Brewer [L].
Dr. Jerry Jacobs [R] and Dr. Chester Fink [L] Figure 5
Dr. Jerry Jacobs [R] and Dr. Chester Fink [L].Pediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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ibly able young adult rheumatologist. We became friends
over the years, and his help later was quiet but effective.
The discussion was heated. I was the only one who felt
that these children must not be put to bed. The traditional
thinking at the time was to put adults and children to bed
in hospitals for as long as their health insurance lasted.
Dr. Polley was so persuaded about the usefulness of bed
rest that he said that he would return to the Mayo Clinic
and put a few children with JRA to bed for six months and
show the improvement in their joint X-rays. I heard later
that he never was able to put any children to bed because
pediatricians there were opposed to that practice.
Another belief of the adult group was that children with
arthritis were a medical curiosity and were extremely rare.
My thesis to them was that if meaningful care or facilities
were available to the children, the parents would bring
them. I suggested that cases of children with arthritis were
not rare at all.
Dr. Christie, our host, then rose and spoke to the group
for the first time. "I am not a rheumatologist, but as a
pediatrician I know that you must not put these children
to bed." He then left us. The effect was powerful. This to
me was a pivotal meeting for pediatric rheumatology.
Warm Springs meeting 1959 – Basil O'Connor MOD
The next pivotal meeting was at Warm Springs in 1959
with Basil O'Connor [figure 7], the respected founder of
the MOD. The meeting was again small and was at Presi-
dent Roosevelt's Warm Springs retreat near Calloway Gar-
dens in Georgia. I don't recall the total group beyond Bill
Clark, Basil O'Connor, Ephraim Engelman, a rheumatol-
ogist from San Francisco, and myself. It was a powerful
and historic meeting place. Basil O'Connor told the story
of the early plans for polio care and research that took
place in the very room where we sat. He felt that we
should not be shy about moving forward.
Mr. O'Connor told us the story of the last days of Presi-
dent Roosevelt at Warm Springs before his death. It was a
moving experience for all of us and gave me a sense of des-
tiny for our new efforts. With Basil O'Connor's approval,
Dr. Clark quickly moved to establish Special Treatment
Centers for JRA under the auspices of the MOD.
March Of Dimes, William Clark, Special Treatment 
Centers 1960
Texas Children's Hospital was among the first centers
approved by the MOD. Joe Levinson in Cincinnati and
John Calabro in New Jersey were directors of other funded
centers. Other centers were added later. Our center's fund-
ing allowed hiring Mrs. Elizabeth Barkley as our physical
therapist, and purchasing needed equipment. In 1962 fur-
ther funding allowed me to become a half time faculty at
Baylor and Texas Childrens Hospital. Soon thereafter
there was a transition of funding support from the MOD
to the Arthritis Foundation as the MOD felt more at ease
with supporting neonatology programs under Virginia
Apgar as their major funding interest. Bill Clark trans-
ferred our movement to the Arthritis Foundation success-
fully with the help of the MOD.
My transition to Texas Childrens Hospital, Baylor College 
of Medicine, and Kelsey Seybold Clinic in 1961–1962
A major problem with the success of our fledgling and
unsophisticated program was that I could only devote one
full day each week to it. Our commitments now exceeded
my time limits. Dr. Blattner and Dr. Mavis Kelsey then
engineered a complex arrangement that brought me back
to Houston full time. I remain grateful to both. Dr. Blat-
tner obtained a grant from the MOD for a half time salary.
This allowed me to be Assistant Professor of Pediatrics at
Baylor and Director of the burgeoning program of the
clinic. It also provided me with time in the lab for research
projects. I had worked my way through college and med-
ical school working in laboratories. Dr. James Kemper and
Dr. Alfred Leiser also were crucial to the success of our
program.
Dr. Mavis Kelsey, also a mentor and friend, is a pioneer at
our Texas Medical Center. He founded his private clinic in
1949 after training at the Mayo Clinic. His dream was to
build a large, multidisciplinary clinic. He did. The clinic is
now the largest in Houston with over 300 doctors and 20
branches. In 1961 his clinic had six or seven doctors, and
all were internal medicine specialists, mostly trained at
the Mayo Clinic. He wanted to expand the scope of the
clinic and invited me to found and chair the pediatric
department. I accepted. He paid the other half of my sal-
ary. I arranged my time in the early days by working in the
lab at Baylor in the Microbiology Department, and at the
TCH clinic in the mornings and at the Kelsey Seybold
Clinic (KSC) in the afternoons. My role was to build a
pediatric practice at KSC (Kelsey-Leary Clinic in the early
days). There are now 60 or more pediatricians in the clinic
Dr. Ralph Block [MOD], Brewer, and Basil O'Connor,  Founder March Of Dimes Figure 7
Dr. Ralph Block [MOD], Brewer, and Basil O'Connor, 
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spread over 21 or more branch clinics. I was chair for over
20 years. Both programs became more successful than I
ever imagined. Juggling time requirements did not end
until I retired in 1990.
II : ARA-JRA SUBCOMMITTEE 1963
Marion Ropes, then President of the American Rheuma-
tism Association (ARA), appointed J. Sydney Stillman,
Boston, to be chairman of the first Juvenile Rheumatoid
Arthritis Criteria Subcommittee to study classification. I
was named chairman in 1964 and served until 1977 when
James Cassidy, Ann Arbor, assumed the chair.
The other members of the original committee were Ches-
ter Fink (Dallas), William Gibson (Columbus) 1965–68
followed by Jack Bass (Columbus) 1968- [figure 8], Jerry
Jacobs (New York City), Milton Markowitz (Baltimore
and Hartford), William Reynolds (ex-officio, New York
City), Jane Schaller (Seattle) [figure 9], J. Sydney Stillman
(Boston), and Stanley L. Wallace (ex-officio, Brooklyn).
The appointment of a subcommittee for was a truly piv-
otal event for pediatric rheumatology. Marion Ropes was
a Professor of Medicine at the Massachusetts General Hos-
pital and Harvard Medical School and represented the
most conservative element of the adult rheumatology
world. Her friend, Sydney Stillman, Director of the Robert
Breck Brigham Hospital rheumatology program, also at
Harvard, persuaded her that studies of children with
arthritis needed to be done and that a standard classifica-
tion was needed to allow studies to be performed. Most
adult rheumatologists at the time believed that children
with JRA were a medical curiosity and rare in frequency.
Milton Markowitz was a mentor to the group and was
older. He was at John Hopkins during this time. He soon
went to the University of Connecticut as Chairman of
Pediatrics and later as Dean of the medical school. Mark
was a respected authority on rheumatic fever. Like Syd
Stillman, he was a consensus builder, who had a wonder-
ful sense of humor. Mark was raised in New York City and
believed that some of the nicest people in the world were
those who survived the streets of New York as youths and
were still kind and considerate people. He was that per-
son.
William Gibson was a member for a few years at the onset
of the committee's work. Bill was a pediatrician at Ohio
State Medical School in Columbus. He was articulate and
aggressive in his approach to life. Some of us had strong
opinions about life and the criteria. Bill and Jerry Jacobs
had several explosive verbal encounters in our delibera-
tions. Jack Bass replaced Bill on the committee in 1968.
Jack also was a pediatrician in Columbus. He was a larger-
than-life person, athletic in build, booming baritone
voice, and was our bull-in-a-china closet member. As I
remember, Jack played basketball at the University of Mis-
souri and had an athlete's keen sense of competition. He
was devoted to children with arthritis and always fulfilled
his responsibilities in a timely fashion.
Jane Schaller was the youngest member of the group and
became another pediatric rheumatology legend. She was
from the University of Washington in Seattle and later
became Chairman of Pediatrics at Tufts Medical School in
Boston. Jane trained in the United Kingdom with Eric
Bywaters and Barbara Ansell, well known and revered pio-
neers of rheumatology in the UK. Jim Cassidy, Virgil Han-
Dr. Jane Schaller [R] and Dr. Earl Brewer [L] Figure 9
Dr. Jane Schaller [R] and Dr. Earl Brewer [L].
Dr. Jack Bass Figure 8
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son, and Chester Fink also spent time with Eric and
Barbara. Jane was an assertive and able person. Her smile
would light the room and her thoughts were penetrating
and insightful. I was chair, coordinator, facilitator, per-
suader, and motivator of the group and was at Baylor and
Texas Children's Hospital in Houston. William Reynolds
and Stanley Wallace were ex-officio members from the
ARA, and these members changed over the span of years
of committee work.
The committee from the beginning formed a collegial
spirit to develop a classification of JRA that would allow
investigators to perform studies on uniform populations
and provide structure for diagnosis. The committee took
three approaches serially: (1) The committee exercising
clinical judgment and experience, wrote a tentative criteria
with exclusions to be tested. (2) A survey of clinical man-
ifestations of 249 JRA patients was taken. (3) A prospec-
tive study of patients involving 135 JRA children and 100
non-JRA children with rheumatic complaints was
done.[4]
(1)Classification I: empirical JRA definition with manifestations
The committee, all experienced in the care of children
with JRA, developed 11 clinical manifestations with
arthritis as a necessary component. Each manifestation
was carefully defined. Exclusions were included. The orig-
inal classification items to be tested were polyarthritis
(two or more joints), monarticular arthritis, rheumatoid
rash, rheumatoid factor, iridocyclitis, cervical spine
involvement, pericarditis, tenosynovitis, intermittent
fever, morning stiffness, and subcutaneous nodules. This
grouping was termed Classification I. The committee felt
that the clinical manifestations of JRA were so varied that
exclusions were necessary for a valid classification. The
exclusions were detailed and numerous.
Our collegial experience was that polyarthritis (two or
more joints) present for three months or longer would
allow a diagnosis unless an exclusion condition was
present. Polyarthritis present for six weeks or less with one
of the defined manifestations would allow diagnosis
unless an exclusion diagnosis was present.
Spirited discussions were the hallmark of our first project
together. We all felt the need and pressure to complete our
task successfully. We knew that this would be our first,
last, and only opportunity to move our cause forward.
Our meetings were often in conjunction with other pedi-
atric or ARA meetings. As I remember, we usually paid for
our own expenses. We had a limited budget.
Even though detailed descriptions were made of the
prominent manifestations, the inclusion of so many
exclusions created the criticism that the classification was
simply an exclusion diagnosis of chronic inflammatory
arthritis to be classified when all other diagnoses were
eliminated. We called this effort, Classification 1.
One has to remember that there was no unanimity on
what JRA was. We carefully read Dr. George Frederic Still's
classic description of what became Still's Syndrome from
the Great Ormond Street Hospital in London. His first
paper was for his dissertation at Cambridge in 1895, and
his second paper was from the Medico-Chirurgical Trans-
actions, London, 1897. [5] Jane Schaller found his origi-
nal paper in the archives of the London hospital at a later
date. The thrust of our work was to develop a classifica-
tion that would allow researchers everywhere to study
children with JRA and obtain results that others would
understand and accept.
I remain fascinated by the many intellectual discussions
regarding why we were NOT developing a diagnostic cri-
teria, but rather a classification of JRA for researchers. The
discussions were passionate. I pointed out that no matter
what we wrote, physicians would use the classification as
diagnostic criteria. In fact, that is exactly what happened.
The importance of diagnostic criteria versus classification
discussions was relevant. We concluded that our further
studies would try to develop criteria that would have high
specificity for JRA, even if the sensitivity were low to help
researchers who needed to eliminate other diseases by
specificity data and not exclusions. My personal opinion
was that physicians caring for JRA children needed nail-in-
the-wall criteria that would aid in treatment decisions and
diagnostic decisions. The retrospective survey was the ini-
tial move to ascertain if we could establish a time frame
for earlier diagnosis. Six months was the time range for
the adult RA criteria. We hoped to reduce that time frame
with the initial review as well as verify that our clinical
experience had validity.
(2) Retrospective survey of JRA patients
We concluded that we must not report to the ARA a com-
pilation of eleven learned manifestations of JRA with no
substantiating data and pass muster with our charge.
Therefore, our next phase was to ascertain how soon the
eleven items occurred in children with JRA diagnosed by
experienced physicians. We needed to know how soon
JRA could be classified after clinical onset. We also would
learn whether data would validate our clinical judgment
and experience. There was considerable discussion about
creating a self-fulfilling classification. We addressed this
legitimate concern with the second and third phases of
our project.
The directors of nine clinics completed a retrospective sur-
vey to ascertain when the 11 clinical manifestations listedPediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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by the committee first occurred in their patients. All
patients included had to have arthritis as a manifestation
and were believed to have JRA by the physician. The par-
ticipants were James Cassidy, Chester Fink, William Gib-
son, Robert Hill (Vancouver), Ralph Jacox (Rochester,
NY), Joseph Levinson (Cincinnati), Milton Markowitz,
and Jane Schaller. Benjamin Duran, Ph.D. (statistician,
Houston) and I analyzed the data and participated in the
data collection.
Of the 249 patients analyzed, 214 children would have
been diagnosed in six weeks or less in terms of classifica-
tion I; Nineteen additional patients would have been
diagnosed within three months. Sixteen patients would
not have been diagnosed by three months (6 percent error
rate). Criteria I successfully identified 94% of JRA patients
within three months. The sixteen patients not diagnosed
had manifestations of disease other than arthritis in the
first three months. By one year, ten of these patients devel-
oped arthritis, and six patients had arthritis after one year.
(3) Prospective study: computer analysis of JRA and Non-JRA patients 
with rheumatic complaints
The next necessary step was to design and perform a pro-
spective, comparative study of JRA and non-JRA patients
with arthritis. Our hope was that we would find that a
classification could be developed from the database to
allow flexibility and accuracy for differing needs of
researchers. We also wanted to develop a general classifi-
cation that would possess acceptable sensitivity and spe-
cificity to satisfy needs of researchers and practitioners.
Two hundred thirty-five patients (135 JRA and 100 non-
JRA) from 16 centers were examined by center directors,
or designated associates, during a specified nine-month
period and examined again four to six months later. All
patients with rheumatic complaints seen by the desig-
nated examiner were included. Patients had to be new to
the examiner, but not necessarily a new JRA or non-JRA
patient with rheumatic complaints. A detailed protocol
was observed
Sixty-six different clinical manifestations and 23 labora-
tory items were recorded. Arthralgia was not included. The
examiner made a diagnosis of JRA based on his/her own
experience. There were 33 separate diagnoses in the 100
non-JRA patients. The largest number (17) had rheumatic
fever.
Benjamin Duran then performed the statistical analysis.
He was a joy to know, and it was a pleasure to work with
him. The data was massive, and we programmed the data
for exhaustive cluster analysis. Remember that we were
working in the 1960's – the dark ages of computers. The
computer with which we worked was housed in a huge,
air-conditioned room and required enormous, tender,
loving care.
The basic structure of the study remains a classic endeavor
to me. On a prospective basis, we enrolled all patients
with rheumatic complaints referred and examined by 18
center directors during a nine-month entry period. The
patients had to be new to the examiner, but not new to
rheumatic complaints. The design was close to the reality
of pediatric rheumatology practice and made the results
more relevant. I was delighted that the chance distribution
was 135 to 100 JRA vs. non-JRA.
Analysis of the 89 items (66 clinical and 23 laboratory)
presented a challenge. The chief problem was to reduce
the large number of clinical manifestations in such a way
that would be compatible with clinical judgment. A clus-
ter analysis technique, which made use of the qualitative
nature of the data (presence/absence data), was used to
cluster similar (correlated) items. This method of analysis
did not yield better results than those obtained by subjec-
tively forming clusters of items.
Sensitivity and specificity of 89 individual items were used
to arrive at the classification that we could recommend for
approval. Sensitivity was defined as the percent of JRA
patients having a particular manifestation present. Specif-
icity was defined as the percent of non-JRA patients hav-
ing a particular manifestation absent. For example,
polyarthritis occurred in 108 of 135 JRA patients and 40
of 100 non- JRA patients. The sensitivity was 80 % and
specificity was 60% for this item. Unfortunately no indi-
vidual sensitivities or specificities yielded a 95% or better
result.
We examined whether time from onset of disease could be
helpful in early classification. We were surprised to find
that 3, 6, 12 weeks and beyond yielded no increase in sen-
sitivity or specificity. Even at 12 weeks or longer from dis-
ease onset 73% of JRA patients remained along with 41%
of non-JRA patients. Counter to our collective, intuitive,
clinical belief, 19% of the non-JRA patients remained after
3 months of disease. This meant that duration of disease
beyond 12 weeks in itself was not helpful in the absence
of exclusions.
We exhaustively examined combinations of items. Several
hundred combinations were considered in our effort to
find a significant relationship between JRA patients and
controls. None reached 95% sensitivity or specificity.
Symmetrical joint involvement did reach 70% sensitivity
and 61% specificity. We attempted to show whether a cer-
tain number of joints would increase selectivity. To elim-
inate all but five percent of non-JRA patients wouldPediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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require 11 joints or more in the JRA population. The yield
was too low to be effective as a classification.
This study did not provide any diagnostic help with mon-
articular arthritis. Most children added more joints after
a few months. In a later study we classified pauciarticular
arthritis as a separate subtype.
Many clinicians at the time felt that pericarditis was a def-
inite item for classification. The data showed that there
were more non-JRA children (five) than JRA children
(four).
Fever also is an important component of JRA. Many of us
had the mistaken idea that intermittent fever that lasts
longer than six weeks is virtually diagnostic of JRA. Seven
percent of JRA children had intermittent fever longer than
six weeks, but four percent of non-JRAs also intermittent
fever lasting longer than six weeks. Twenty-seven percent
JRA and 28 % and non- JRA had lymphadenopathy. Of
interest is that four JRA and no non-JRA children had
epitrochlear nodes. Iridocyclitis occurred in four percent
of JRAs and one non- JRA. This was an example of low sen-
sitivity and high specificity.
Subcutaneous nodules occurred in six JRAs (five had a
positive rheumatoid factor). Two non-JRAs with subcuta-
neous nodules had a negative rheumatoid factor.
Laboratory and x-ray data were not done in the same labs
and could not really be analyzed statistically. Consistent
tests were not done in each center.
Classifications II and III represented inclusion of all items
of classification plus contracture of a joint and subjected
the nine items to cumulative sensitivity and specificity cal-
culations. The committee continued its work to validate
and further refine it. We added subtypes: Systemic JRA,
Pauciarticular JRA, and Polyarticular JRA. Cassidy,
Schaller, and others established the relationship between
iritis and Pauciarticular JRA.
The next project was to validate the newer data. [6] We
used Joe Levinson's data at Cincinnati under Jim Cassidy's
leadership. It was at this point that we used the new skills
of computer technology with Jim Fries of Stanford Medi-
cal School. One memorable meeting took place at Joe Lev-
inson's mountain home in Jackson Hole, Wyoming. Joe's
house had large picture windows that provided a post card
view of the Grand Teton mountain range. We shared bed-
rooms, and we made Jerry Jacobs and Chet Fink sleep in
the same room because they snored so loudly. Jim Fries
came to our meeting and showed off his new technology
by Internet connecting to his home computer at Stanford
in California. He showed us the capacity of analyzing data
from several centers and joint meetings. It was a new
world.
Joe and Jim were the leaders in the next phase of the crite-
ria project, and the reader is directed to their recollections
and data [7]. We were fortunate to have such able physi-
cians as Jim Cassidy and Joe Levinson.
III : publication of JRA book 1970 [8]
A. First edition
Mark Markowitz was a dedicated member of our JRA Sub-
committee. He was probably the most prestigious mem-
ber along with Sydney Stillman. Mark was well known for
his studies with the streptococcus and rheumatic fever. He
worked for several years in Israel in a lab with Ruth Kut-
tner. At Johns Hopkins he was a contributor to the Pediat-
ric Clinics of North America published by W. B. Saunders
& Company of Philadelphia. They were the largest pub-
lisher of medical books at that time in the 1960's. The
series of books were classic. Mary Ellen Avery's classic
Neonatology books came from this series and other
authors' such as Mark and Ruth's book on rheumatic fever
became classic books.
Mark and Alexander Schaeffer kindly asked me to write a
book on JRA for the series. The other authors were well-
known, well-published people. I was not. The opportu-
nity was incredible. No one in pediatrics had written a
book on JRA at that time, and Mark and his publisher
Saunders thought that it would help to bring children
with JRA to the consciousness of pediatricians. It was liter-
ally the blind leading the blind to write the book. My sav-
ior was a then-new-book editor at Saunders, Buck Rowan.
He worked with me to structure a book properly. Years
later several authors for Saunders told me that they were
told to read my book to see how a book should be done.
The reason was that my book was Buck's first assignment
at Saunders. He became Editor-in-Chief years later. I
started the arduous task in 1968, working at home in the
evenings from 10 pm to after midnight. I enlisted the help
of Elizabeth Barkley, our physical therapist, Ed Singleton,
head of radiology at TCH (Texas Children Hospital), Mal-
colm Granberry, our orthopedist, Dan McNamara, head
of cardiology at TCH, and Sidney Cleveland, our psychol-
ogist.
As a sign of the era, we devoted 8 pages to aspirin, 17
pages to steroids, 9 pages to gold therapy, 6 pages to
indomethocin, a paragraph each to chloroquine and
cyclophosphamide. The data reported was by-and-large
our own data. There were remarkably few studies in chil-
dren, and we analyzed our own patient base for most of
the data. Our exercise program, a fundamental base to our
treatment, received 23 pages.Pediatric Rheumatology 2007, 5:11 http://www.ped-rheum.com/content/5/1/11
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The book sold several thousand copies chiefly due to the
subscription list of Saunders. I was amazed. I learned a
great lesson here. Many of my colleagues spent large
amounts of time on national speeches and local talks in
the hospital such as grand rounds. These efforts are essen-
tial for the education of our students, residents, and oth-
ers. But as a tool to spread the word nationally and
internationally about children with arthritis, the printed
word lasts many times longer than any speech.
I was dumbfounded in 1976 to find my book in Lenin-
grad, USSR. A group of rheumatologists including myself
were in the USSR as part of the newly implemented USA-
USSR scientific cooperation. I was the only pediatrician in
the group of 12 or 14. We went to the offices of Professor
Igor Vorontsov, head of pediatrics in Leningrad. He was in
charge of the health of about one million children. He was
also a pediatric rheumatologist. Rheumatology was one of
the strong specialties in the USSR, and he had a substan-
tial center with twenty or more physicians and accompa-
nying staff. He was slightly plump, jolly but soft-in-speech
man with a playful look in his eye. He quickly perceived
that our adult rheumatology colleagues outnumbered us.
Igor motioned me to come to his private office. Remem-
ber, that this was the middle of the cold war. He smiled
and reached to his large, office library shelf and pulled a
copy of my book. He told me that he read from it daily. I,
of course, didn't believe that, but we had no idea that Rus-
sians had access to any of our books.
B. Second edition of JRA Book [9]
In 1973 Buck Rowan and I persuaded Jack Handy, the edi-
tor-in-chief of Saunders and Alexander Schaeffer, the con-
sulting editor, that a second edition was useful. Pediatric
rheumatology was moving ahead, and I wanted to keep
up the momentum of our efforts. Unfortunately. my work
load and lack of free time peaked in those years, and the
book took a back seat for a few years. There were a number
of letters from Buck wishing for more of my time to work
on the book. Elizabeth Barkley and I did publish our Par-
ents' Manuel with Saunders in 1975. Saunders also
wanted to be a part of Park City I.
Buck Rowan was promoted in 1976, and George Vilk
became my assigned editor. There is a memorable letter in
my papers from me to George telling him that the book
would be finished in 1976 -ho,ho,ho. The chapters were
slow to be finished. I settled on writing three evenings
each week with the help of our new associate, Ed Gian-
nini. We lined all four walls of our dining room with
reprints in metal separators. My wife Ria's mother was
appalled. We had many dinner parties in the formal din-
ing room surrounded by thousands of pages of data and
reprints. It is hard to remember pre-computer data file
days now. Ed lived with us three days each week with a
pull down bed in our library. He had to use the one bath-
room upstairs in the children's bedroom area and shared
it with three of our children. I still hear from them about
Ed. He spent so much time getting ready that they rou-
tinely pounded on the door. The regimen that Ed and I
established was effective, and we completed the book by
1980. Mary Cowell had become the assigned editor in
1978. Ed and I decided to add Don Person, a colleague, as
an author to get help in completing chapters, and we all
struggled to finish the task.
As an example of how far drug therapy had progressed in
childhood arthritis in 12 years, the first edition devoted
42 pages to drug therapy, while the second edition
devoted 104 pages with many more medicines added and
some eliminated. The second edition was published in
1982 and was successful.
Other landmark, published books in pediatric rheuma-
tology: John J Miller III published Juvenile Rheumatoid
Arthritis in 1979. Barbara Ansell published Disorders in
Childhood (1980), Cassidy published the first edition of
Textbook of Pediatric Rheumatology (1982). Jerry Jacobs
published Pediatric Rheumatology for the Practitioner
(1982). Gershwin and Robbins published Musculoskele-
tal Disease of Children (1983).
Parts II and III will be published soon in Pediatric Rheumatology
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